Hypera S.A. (OTCMKTS:HYPMY – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The stock traded as low as $4.83 and last traded at $4.83, with a volume of 4551 shares changing hands. The stock had previously closed at $4.99.
Hypera Price Performance
The stock has a 50-day moving average of $5.26 and a 200-day moving average of $5.97.
Hypera (OTCMKTS:HYPMY – Get Free Report) last issued its earnings results on Thursday, July 25th. The company reported $0.15 EPS for the quarter. The business had revenue of $420.00 million during the quarter.
About Hypera
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Read More
- Five stocks we like better than Hypera
- Airline Stocks – Top Airline Stocks to Buy Now
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 7/29 – 8/2
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
